All research staff – University of Copenhagen

Faculty of Law > Staff > All research staff

Timo Minssen

Timo Minssen

Director of centre, professor

Timo Minssen is Professor of Law at the University of Copenhagen (UCPH) and the Founding Director of UCPH's Center for Advanced Studies in Biomedical Innovation Law (CeBIL). His research concentrates on Intellectual Property-, Competition & Regulatory Law with a special focus on new technologies in the pharma, life science & biotech sectors. This involves a plethora of legal issues emerging during the lifecycle of biotechnological and medical products and processes -  from the regulation of research and incentives for innovation to technology transfer and commercialization. Timo is presenting frequently on a wide variety of pressing topics at international IP symposia, major law firms, the Universities of Oxford & Cambridge, Harvard Law School, MIT, and at the European Medicines Agency etc.. He has written 2 books and published 80+ articles and book chapters in leading international publications, such as Nature Biotech, PLoS-Computational Biology, Biotech. J., BLR, Person.Med., IIC, EIPR, ECLR, JIPLP, GRUR Int., Chi.-Kent J. Intell. Prop., IPQ, QMJIP, ERT, NIR & EUConst.LR. He is also a regular contributor on Harvard Law School's "Bill of Health" blog. Prior to founding CeBIL, Timo headed CIIR's  Copenhagen Biotech & Pharma Forum (CBPF).

Main research area

  • Pharmaceutical-, Life Science- & Biotech Law
  • Comparative European & US Patent Law
  • AI & Big Data in the Health & Life Sciences
  • Intellectual Property Law & Open Innovation
  • EU Competition- & US Antitrust Law

Fields of interest

  • Synthetic Biology & Nanotechnology
  • Law & (Emerging) Technologies
  • EU Law
  • Medical & Health Law
  • E-Health & Big Data

Appointments

Past appointments

Editorial tasks

Peer-review

  • IIC- International Review of Intellectual Property and Competition Law
  • The Lancet
  • European Pharmaceutical Law Review
  • QMJIP- Queen Mary Journal of Intellectual Property
  • PLOS Biology

Research management

  1. Collaborative Research Program in Biomedical Innovation Law (Principal Investigator)
  2. Co-supervisor for a PhD thesis and collaborator in an interdisciplinary research project on "Regulation of Biosimilars" (in co-operation with the Copenhagen Centre for Regulatory Sciences (CORS) and the Faculty of Health and Medical Sciences

Completed:

  1. Global genes, local concerns: Legal, ethical and scientific challenges in cross-national biobanking and translational exploitation (Principal Investigator, WP leader & steering committee member, 1 PhD student)
  2. CoNEXT - Fertilizing the ground and harvesting the full potential of the new neutron and X-ray research infrastructures close to UCPH (coPI, WP leader & steering committee member, 1 PostDoc)
  3. BioSYNergy: Synthetic Biology - towards a Bio-Based Society (coPI, WP leader & steering committee member, 1 PhD student and post Doc)
  4. AdManI: Additive Manufacturing and Innovation: Technical, Economic, Legal, and Policy Related Aspects of Rising Technologies (International Research Partner)
  5. User Generated Law: Re-constructing Law in the Knowledge Society (coPI, WP leader)
  6. Co-supervisor for a PhD thesis and collaborator in an interdisciplinary research project on "Counterfeit Medicines" (in co-operation with the Faculty of Health and Medical Sciences).

PhD students

  • Behrang Kianzad - Excessive prices, competition law & compulsory licenses in the pharma sector (supervisor)
  • Ivan Hadaya - IPRs in IoT & Health Tech (appointed supervisor)
  • Vadym Semenov -SSO policy, FRAND and right for injunction (co-supervisor)
  • Louise Christine Druedahl - Regulation of Biosimilars (co-supervisor at KU Health)

Completed:

PostDocs related to research projects

Teaching

Teaching in courses for Professionals and PhD -students

Selected publications

  1. Published

    Patents and Technological Progress in a Globalized World-Liber Amicorum Joseph Straus: A review

    Minssen, T. 2012 In : The IP Law Book Review. 2, 2, p. 83 - 102 20 p.

    Research output: Contribution to journalLiterature reviewResearchpeer-review

  2. Published

    Refusal to Supply in the EU Pharmaceutical Sector under the Rule of Reason

    Nguyen, T. T., Groussot, X. & Minssen, T. 2011 National Developments in the Intersection of IPR and Competition Law: from Maglite to Pirate Bay. Lidgard, H. H. (ed.). Oxford / Portland: Hart Publishing, Vol. 3, p. 283-306 23 p. (Swedish Studies in European Law - No. 3).

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

  3. Published

    A Sequel to "US Patent Eligibility in the wake of Bilski v. Kappos": "Business as Usual in an Age of New Technologies?"

    Minssen, T. & Schwartz, R. 2011 In : Biotechnology Law Report. 30, 1, p. 57 - 58 2 p.

    Research output: Contribution to journalReviewResearchpeer-review

  4. Published

    US Patent Eligibility in the Wake of Bilski v. Kappos: Business as Usual in an Age of New Technologies?

    Minssen, T. & Schwartz, R. 2011 In : Biotechnology Law Report. 30, 1, p. 3 - 56 54 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Meanwhile On the Other Side of The Pond: Why a biopharmaceutical invention that was "obvious to try", still might not be obvious - Part I

    Minssen, T. 2010 In : Chicago Kent Journal of Intellectual Property Law. 9, p. 60-131 71 p.

    Research output: Contribution to journalReviewResearchpeer-review

  6. Published

    Restoring the balance: The Patentability of DNA-related Technology in the US and Europe

    Minssen, T. Mar 2009

    Research output: Other contributionNet publication - Internet publicationResearch

  7. Published

    The Rule of Reason under Article 82 EC after Sot Lelos Kai Sia

    Minssen, T., Nguyen, T. T. & Groussot, X. Jun 2009

    Research output: Working paperResearch

  8. Published

    När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa

    Minssen, T. 2008 In : NIR : Nordiskt immateriellt rättsskydd. 77, 4, p. 339 - 387 48 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published
  10. Published

    Es bleibet dabei: Eine schwedische Stellungnahme zur europäischen Debatte über den absoluten Erzeugnisschutz bei der DNA-Patentierung – Teil 2

    Minssen, T. 2008 In : Klinische Forschung und Recht. 3, 4, p. 105 - 120 17 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Es bleibet dabei: Eine schwedische Stellungnahme zur europäischen Debatte über den absoluten Erzeugnisschutz bei der DNA-Patentierung – Teil 1

    Minssen, T. 2008 In : Klinische Forschung und Recht. 3, 3, p. 93 - 97 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Zur Zulässigkeit von Feststellungsklagen im US Lizensrecht nach den Entscheidungen in MedImmune und SanDisk

    Minssen, T. & Schindler, G. 2008 In : Gewerblicher Rechtsschutz und Urheberrecht. Internationaler Teil. 57, 3, p. 192 - 200 20 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    The US examination of nonobviousness after KSR v. Teleflex with special emphasis on DNA Related Inventions

    Minssen, T. 2008 In : IIC - International Review of Intellectual Property and Competition Law. 39, 8, p. 886 - 916 30 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    Obesvarade frågor rörande patent på datorrelaterade uppfinningar och affärsmetoder? Reflektioner kring Alain Pompidous brev till Lord Justice Jacob

    Minssen, T. & Gozzo, G. 2007 In : NIR : Nordiskt immateriellt rättsskydd. 76, 3, p. 220 - 245 26 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Res Judicata i EG-domstolens rättspraxis: En avvägning mellan rättssäkerhet och lagenlighet

    Minssen, T. & Groussot, X. 2007 In : Europarättslig tidskrift. 10, 3, p. 535 - 567 32 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. Published

    Res Judicata in the ECJ Case Law: Balancing Legal Certainty with Legality?

    Minssen, T. & Groussot, X. 2007 In : European Constitutional Law Review. 3, 3, p. 385 - 417 32 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  17. Published

    Patenting Human DNA sequences in Europe and the U.S. A comparative analysis of patentability requirements for nucleic acid sequences

    Minssen, T. 2005 Lund University Press. 163 p.

    Research output: Book/ReportBookResearchpeer-review

Selected activities

  1. The Scope of Protection for Biotech-Patents after Monsanto v. Cefetra

    Minssen, T. (Speaker)
    8 Nov 2011

    Activity: Talk or presentationLecture and oral contribution

  2. IPR's and Biobanks - Barriers for Translational Exploitation?

    Minssen, T. (Speaker)
    5 Oct 2011

    Activity: Talk or presentationLecture and oral contribution

  3. The CAFC's decision in the "Myriad" gene patenting case: Background, outcome and ramifications

    Minssen, T. (Speaker)
    16 Sep 2011

    Activity: Talk or presentationLecture and oral contribution

  4. Recent developments in U.S. and European Patent Law & Policy

    Minssen, T. (Organizer)
    13 Sep 2011

    Activity: Participating in or organising an eventOrganisation of and participation in conference

  5. Pharmaceutical IPR and public health in an era of global challenges

    Minssen, T. (Speaker)
    10 Aug 2011

    Activity: Talk or presentationLecture and oral contribution

ID: 16150437